A new malaria vaccine achieves an unparalleled 89% efficacy by targeting late-liver-stage antigens, unlocking new horizons in the fight against global disease. Study: Safety and Efficacy of ...
OS Therapies submits patent application with US FDA covering biomarkers of immune response to Listeria monocytogenes: New York Saturday, April 18, 2026, 16:00 Hrs [IST] OS Therapi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results